Biologics in systemic lupus erythematosus: current options and future perspectives

被引:6
|
作者
Yusof, Yuzaiful Md [1 ,2 ]
Vital, Edward M. [1 ,2 ]
Emery, Paul [1 ,2 ]
机构
[1] Univ Leeds, Chapel Allerton Hosp, Leeds Inst Rheumat & Musculoskeletal Med, Leeds LS7 4SA, W Yorkshire, England
[2] Leeds Teaching Hosp NHS Trust, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England
关键词
B-LYMPHOCYTE STIMULATOR; DOUBLE-BLIND; DISEASE-ACTIVITY; PHASE-III; EFFICACY; SAFETY; NEPHRITIS; RITUXIMAB; BELIMUMAB; MANIFESTATIONS;
D O I
10.12968/hmed.2014.75.8.440
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:440 / 447
页数:8
相关论文
共 50 条
  • [1] Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives
    Magro-Checa, Cesar
    Zirkzee, Elisabeth J.
    Huizinga, Tom W.
    Steup-Beekman, Gerda M.
    DRUGS, 2016, 76 (04) : 459 - 483
  • [2] A review of systemic lupus erythematosus and current treatment options
    Bernknopf, Allison
    Rowley, Kristina
    Bailey, Teresa
    FORMULARY, 2011, 46 (05) : 178 - +
  • [3] Current and future treatment options for cutaneous lupus erythematosus
    Hansen, Christopher B.
    Callen, Jeffrey P.
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (07): : 777 - 786
  • [4] Biologics in the treatment of systemic lupus erythematosus
    Lateef, Aisha
    Petri, Michelle
    CURRENT OPINION IN RHEUMATOLOGY, 2010, 22 (05) : 504 - 509
  • [6] Current Perspectives on Imaging for Systemic Lupus Erythematosus, Systemic Sclerosis, and Dermatomyositis/Polymyositis
    Kolasinski, Sharon L.
    Chi, Andrew S.
    Lopez-Garib, Angel J.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2016, 42 (04) : 711 - +
  • [7] Targeting Interferons in Systemic Lupus Erythematosus: Current and Future Prospects
    Alexis Mathian
    Miguel Hie
    Fleur Cohen-Aubart
    Zahir Amoura
    Drugs, 2015, 75 : 835 - 846
  • [8] Systemic lupus erythematosus: an update on current pharmacotherapy and future directions
    Touma, Zahi
    Urowitz, Murray B.
    Gladman, Dafna D.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (05) : 723 - 737
  • [9] Anifrolumab in systemic lupus erythematosus: current knowledge and future considerations
    Anderson, Erik
    Furie, Richard
    IMMUNOTHERAPY, 2020, 12 (05) : 275 - 286
  • [10] Targeting Interferons in Systemic Lupus Erythematosus: Current and Future Prospects
    Mathian, Alexis
    Hie, Miguel
    Cohen-Aubart, Fleur
    Amoura, Zahir
    DRUGS, 2015, 75 (08) : 835 - 846